Abatacept Pre-Filled Syringe/ Autoinjector Suppliers & Bulk Manufacturers
Available Forms: Pre-filled Syringe or Autoinjector
Available Strengths: 125 mg/0.5 mL, 250 mg/1 mL
Reference Brands: Orencia(US & EU)
Category:
Arthritis
Abatacept inhibits T-cell activation by blocking CD80/CD86 co-stimulatory signals, reducing inflammation and immune response in rheumatoid arthritis. Benefits include rapid symptom relief, improved joint function, slowing disease progression, and convenient subcutaneous autoinjector or syringe administration, enhancing patient adherence and quality of life for autoimmune disease management.
Abatacept Pre-filled Syringe/ Autoinjector is available in Pre-filled Syringe or Autoinjector
and strengths such as 125 mg/0.5 mL, 250 mg/1 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Abatacept Pre-filled Syringe/ Autoinjector is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Abatacept Pre-filled Syringe/ Autoinjector can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Abatacept pre-filled syringes and autoinjectors are approved in the EU and US for rheumatoid arthritis and other autoimmune diseases. In the EU, brands like Orencia are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, FDA approval is based on extensive clinical data, biosimilarity, and pharmacovigilance. Both regions require detailed dossiers for initial approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We support efficient market access for abatacept formulations, ensuring adherence to European and American standards for safe, effective biologic therapy, helping you navigate complex regulatory requirements seamlessly.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing